Breaking News in Spinal Cord Injury Research FDA Approved Phase I Clinical Trial of Human, Autologous Schwann Cell Transplantation in Patients with Spinal Cord Injuries
Xiao-Ming Xu
摘要： On July 31, 2012, The Miami Project to Cure Paralysis at the University of Miami Miller School of Medicine received permission from the Food and Drug Administration (FDA) to begin a Phase I clinical trial to evaluate the safety of transplanting human autologous Schwann cells to treat patients with spinal cord injuries.This is the only FDA-approved cell therapy-based clinical trial for sub-acute spinal cord injury in the United States.
机标关键词：Clinical TrialSpinal Cord InjurySpinal Cord Injuriesclinical trialspinal cord injuriesDrug Administrationspinal cord injurythe United States
论文发表日期：2012-01-01
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：3( 1685-1687 )